Skip to content
Grand Slothouse

Zimbabwe Rejects ‘One-Sided’ US Healthcare Assistance Package Over Information Concerns

Health aid illustration
The offered American financial assistance was aimed at initiatives for HIV/Aids treatment and prevention, TB, and malarial diseases.

Zimbabwe has turned down a substantial American health deal valued at $367m (272 million pounds) over five years due to Washington's insistence on sensitive biological samples.

This rejection was revealed after a government memo from December was leaked, indicating that Head of State Emmerson Mnangagwa believed the agreement was "unbalanced".

A government spokesperson has since clarified that the United States was seeking genetic material for research and commercial gain while was not willing to guarantee the benefits from future treatments.

"We are forced to start the challenging and unfortunate task of scaling back our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.

Her embassy indicated the US had donated more than $1.9bn as health assistance to Zimbabwe during the past two decades.

A physicians' group in Zimbabwe has appealed for further talks to secure a deal acceptable to all parties so the nation's critical HIV programme can proceed.

Broader Implications

This rejection comes after a similar case in neighbouring Kenya, where a high court halted a related health funding agreement following legal challenges were raised about the security of Kenyans' medical information.

After returning to office last year, US President Donald Trump has drastically cut foreign aid and shut down the US Agency for International Development (USAID).

USAID had administered aid for the American government, but Trump stated its expenditure was "inefficient" and his administration was pursuing government-to-government agreements to boost transparency and responsibility.

According to statements, 16 nations in Africa have to date signed similar agreements, representing over $18.3bn in committed funds.

Details of the Declined Deal

The funds for Zimbabwe would have funded "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.

"We are confident this partnership could have provided immense advantages for the people of Zimbabwe, especially the 1.2 million men, women and children presently on antiretroviral therapy via American-funded programmes," Tremont said.

However, official spokesman Nick Mangwana maintained the proposed deal was "unequal".

"The proposal required Zimbabwe to share its biological resources and data for a long time, with no corresponding guarantee of benefiting from any medical innovations – like new medicines or tests – that could result from that provided information," his statement read.

"Put simply, our country would supply the basic resources for medical research with no assurance that the resulting innovations would be available to our citizens if a new pandemic emerge."

National Interest and International Frameworks

He also said that the US's withdrawal from the global health body and its pursuit of bilateral deals were undermining frameworks previously established through the international health agency.

Mangwana gave as an example its Pandemic Benefit-Sharing scheme created to deal with future global health emergencies.

"This framework is intended to ensure that when a nation contributes its data, the benefits – such as vaccines and treatments – are shared equitably, not commercialised exclusively by those with the funds to create them."

The government's concerns regarding the US deal "are not meant as hostility towards the US," Mangwana stressed.

"We welcome further dialogue with our American counterparts on how subsequent co-operation might be arranged in a way that honours the independence and dignity of both nations."

Medical Community Reaction

A leading public health body said it recognised the government's concerns, but suggested that negotiations need to persist given that a large portion of the country's HIV programmes were funded by international support.

"In cases where specific concerns arise, such as those relating to data governance or agreement terms, these can frequently be resolved via technical clarification and mutually agreed protections," it said.

The situation highlights the continuing debate between accepting crucial foreign assistance and protecting a country's data in an increasingly interconnected world.

The writer

Dr. Eric Brown

A nature enthusiast and mindfulness coach who writes about finding joy in life's simple moments.

Grand Slothouse

Type to search articles.